In the present study, we explored the role of ATG7 in the pathogenesis of NAFLD by evaluating the hepatic ATG7 mRNA and ATG7 protein expression in a cohort of patients with NAFLD associated with MO using NW subjects and MO individuals, with NL as control groups. Here, ATG7 is linked to metabolic dysfunction-associated steatotic liver disease.